Author:
Orcel Elody,Hage Hayat,Taha May,Boucher Noémie,Chautard Emilie,Courtois Virginie,Saliou Adrien
Abstract
Abstract
Background
Blood transcriptomic analysis is widely used to provide a detailed picture of a physiological state with potential outcomes for applications in diagnostics and monitoring of the immune response to vaccines. However, multi-species transcriptomic analysis is still a challenge from a technological point of view and a standardized workflow is urgently needed to allow interspecies comparisons.
Results
Here, we propose a single and complete total RNA-Seq workflow to generate reliable transcriptomic data from blood samples from humans and from animals typically used in preclinical models. Blood samples from a maximum of six individuals and four different species (rabbit, non-human primate, mouse and human) were extracted and sequenced in triplicates. The workflow was evaluated using different wet-lab and dry-lab criteria, including RNA quality and quantity, the library molarity, the number of raw sequencing reads, the Phred-score quality, the GC content, the performance of ribosomal-RNA and globin depletion, the presence of residual DNA, the strandness, the percentage of coding genes, the number of genes expressed, and the presence of saturation plateau in rarefaction curves. We identified key criteria and their associated thresholds to be achieved for validating the transcriptomic workflow. In this study, we also generated an automated analysis of the transcriptomic data that streamlines the validation of the dataset generated.
Conclusions
Our study has developed an end-to-end workflow that should improve the standardization and the inter-species comparison in blood transcriptomics studies. In the context of vaccines and drug development, RNA sequencing data from preclinical models can be directly compared with clinical data and used to identify potential biomarkers of value to monitor safety and efficacy.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Della Latta V, Cabiati M, Morales MA, Del Ry S. Bio-molecular evaluation of human transcriptomic profile in whole blood sample: a potential clinical approach? Recenti Prog Med. 2015;106:131–6.
2. Hu L, Yin W, Ma Y, Zhang Q, Xu Q. Gene expression signature of human neuropathic pain identified through transcriptome analysis. Front Genet. 2023;14:1127167.
3. Baghela A, An A, Zhang P, Acton E, Gauthier J, Brunet-Ratnasingham E, et al. Predicting severity in COVID-19 disease using sepsis blood gene expression signatures. Sci Rep. 2023;13:1247.
4. Bartholomeus E, De Neuter N, Meysman P, Suls A, Keersmaekers N, Elias G, et al. Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders. Vaccine. 2018;36:6282–9.
5. Georgiadou A, Dunican C, Soro-Barrio P, Lee HJ, Kaforou M, Cunnington AJ. Comparative transcriptomic analysis reveals translationally relevant processes in mouse models of malaria. Krzych U, Kana BD, Renia L, editors. eLife. 2022;11:e70763.